Narnatumab
Narnatumab (IMC-RON8) is a neutralizing human monoclonal antibody that blocks RON binding to its ligand, macrophage-stimulating protein (MSP), with a Kd of 32 pM. Narnatumab can be used for the research of cancer[1].
Product Specifications
Product Name Alternative
IMC-RON8; LY3012219; Anti-MSPR/RON/CD136 Reference Antibody (narnatumab)
UNSPSC
12352203
Target
C-Met/HGFR; Tyrosinase
Type
Inhibitory Antibodies
Related Pathways
Metabolic Enzyme/Protease; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/narnatumab.html
Purity
99.93
Solubility
H2O
Smiles
[Narnatumab]
Molecular Weight
(145.8 kDa)
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99375/Narnatumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99375/Narnatumab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1
CAS Number
[1188275-92-4]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
